CANBERRA: A Phase II Randomized Clinical Trial to Test the Therapeutic Potential of Oral Vicasinabin in Diabetic Retinopathy by Beatriz G. Armendariz, PhD, Ulrich F.O. Luhman, PhD, Brian Berger, MD, Jules Hernandez-Sanchez, PhD, Katrijn Bogman, PhD, Nikolaos Mitrousis, PhD, Martina Wollenhaupt, MD, David Kent, MD, Andreas Wenzel, PhD, Sascha Fauser, MD, PhD

Get full text